Search Results

You are looking at 231 - 240 of 464 items for :

  • Refine by Access: All x
Clear All
Full access

Randy C. Miles, Christoph I. Lee, Qin Sun, Aasthaa Bansal, Gary H. Lyman, Jennifer M. Specht, Catherine R. Fedorenko, Mikael Anne Greenwood-Hickman, Scott D. Ramsey, and Janie M. Lee

definitions of advanced imaging surveillance. 19 – 23 Panageas et al, 23 for example, who showed advanced imaging surveillance use in 40% of early-stage breast cancer survivors using SEER-Medicare linked data, included breast MRI in their analysis, likely

Full access

Hugo J.A. Adams, John M.H. de Klerk, Rob Fijnheer, Stefan V. Dubois, Rutger A.J. Nievelstein, and Thomas C. Kwee

pretreatment imaging of DLBCL (whether diagnostic CT alone, FDG-PET/CT, MRI, or FDG-PET/MRI) is under continuing development, and surely goes beyond mere integration into the existing NCCN-IPI. Factors such as cost-effectiveness and the ability of pretreatment

Full access

Titilayo O. Adegboyega, Jeffrey Landercasper, Jared H. Linebarger, Jeanne M. Johnson, Jeremiah J. Andersen, Leah L. Dietrich, Collin D. Driscoll, Meghana Raghavendra, Anusha R. Madadi, Mohammed Al-Hamadani, Choua A. Vang, Kristen A. Marcou, Jane Hudak, and Ronald S. Go

, recently addressed by ASCO. 25 A review of 67,847 patients with stage I and II breast cancer from the SEER database showed an increase in the use of systemic imaging from 1992 to 2005 in the form of CT scans, PET scan, and brain MRI. 13 In a survey of

Full access

Barbara Dull, Andrew Linkugel, Julie A. Margenthaler, and Amy E. Cyr

%. 1 In this group of patients, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) recommend standard imaging with diagnostic bilateral mammography and ultrasound; breast MRI may also be used. 3 Additional staging studies are only

Full access

Benjamin E. Greer, Wui-Jin Koh, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Warner K. Huh, Daniel S. Kapp, John R. Lurain III, Lainie Martin, Mark A. Morgan, Robert J. Morgan Jr., David Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small Jr., Nelson Teng, and Fidel A. Valea

, cystoscopy, and proctosigmoidoscopy. More complex radiologic and surgical staging procedures are not addressed in the FIGO classification. In the United States, however, CT, MRI, combined PET-CT, and surgical staging are often used to guide treatment options

Full access

Frank Balis, Daniel M. Green, Clarke Anderson, Shelly Cook, Jasreman Dhillon, Kenneth Gow, Susan Hiniker, Rama Jasty-Rao, Chi Lin, Harold Lovvorn III, Iain MacEwan, Julian Martinez-Agosto, Elizabeth Mullen, Erin S. Murphy, Mark Ranalli, Daniel Rhee, Denise Rokitka, Elisabeth (Lisa) Tracy, Tamara Vern-Gross, Michael F. Walsh, Amy Walz, Jonathan Wickiser, Matthew Zapala, Ryan A. Berardi, and Miranda Hughes

tests, including renal function, liver function, complete blood count, and assessment of coagulation; and (3) imaging, including abdominal ultrasound and abdominal CT or MRI (see “Initial Evaluation” [WILMS-1] in the algorithm). Abdominal ultrasound is

Full access

Presenters: Chad A. LaGrange, M. Dror Michaelson, and Colleen H. Tetzlaff

pain progressing to unsteady gait. MRI revealed a mass at T5 with severe spinal canal stenosis, and the patient was admitted for urgent surgical decompression. Imaging revealed a 5-cm renal mass, “which is concerning for RCC,” he said, as well as

Full access

Mary B. Daly, Jennifer E. Axilbund, Saundra Buys, Beth Crawford, Carolyn D. Farrell, Susan Friedman, Judy E. Garber, Salil Goorha, Stephen B. Gruber, Heather Hampel, Virginia Kaklamani, Wendy Kohlmann, Allison Kurian, Jennifer Litton, P. Kelly Marcom, Robert Nussbaum, Kenneth Offit, Tuya Pal, Boris Pasche, Robert Pilarski, Gwen Reiser, Kristen Mahoney Shannon, Jeffrey R. Smith, Elizabeth Swisher, and Jeffrey N. Weitzel

breast cancer. For example, this risk threshold was used in a recent update to the American Cancer Society (ACS) guidelines on breast screening that incorporates MRI. 124 First-degree relatives of individuals with a known deleterious gene mutation in

Full access

Robert J. Besaw, Adrienne R. Terra, Grace L. Malvar, Tobias R. Chapman, Lauren M. Hertan, and Benjamin L. Schlechter

and her anemia normalized within 5 months. During cycle 6, the patient developed headaches and auditory hallucinations. A brain MRI scan revealed a 3.3 × 3.0-cm right posterior temporal mass of unknown age because no prior brain imaging had been

Full access

Ritesh R. Kotecha, Ronan Flippot, Taylor Nortman, Annalisa Guida, Sujata Patil, Bernard Escudier, Robert J. Motzer, Laurence Albiges, and Martin H. Voss

Cancer Center for patients with mRCC included mandatory brain screening by CT/MRI at study entry. Among 1,689 patients screened, 72 (4.3%; 95% CI, 3.3%–5.3%) were found to have incidental brain metastases without documented neurologic symptoms upon